Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model.

Gregg KA, Harberts E, Gardner FM, Pelletier MR, Cayatte C, Yu L, McCarthy MP, Marshall JD, Ernst RK.

Vaccine. 2018 Jun 27;36(28):4023-4031. doi: 10.1016/j.vaccine.2018.05.101. Epub 2018 May 31.

2.

Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.

Gregg KA, Harberts E, Gardner FM, Pelletier MR, Cayatte C, Yu L, McCarthy MP, Marshall JD, Ernst RK.

MBio. 2017 May 9;8(3). pii: e00492-17. doi: 10.1128/mBio.00492-17.

3.

A review of alcohol-impaired driving: the role of blood alcohol concentration and complexity of the driving task.

Martin TL, Solbeck PA, Mayers DJ, Langille RM, Buczek Y, Pelletier MR.

J Forensic Sci. 2013 Sep;58(5):1238-50. doi: 10.1111/1556-4029.12227. Epub 2013 Jul 23. Review.

PMID:
23879433
4.

Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii.

Pelletier MR, Casella LG, Jones JW, Adams MD, Zurawski DV, Hazlett KR, Doi Y, Ernst RK.

Antimicrob Agents Chemother. 2013 Oct;57(10):4831-40. doi: 10.1128/AAC.00865-13. Epub 2013 Jul 22.

5.

Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.

Morris EJ, Jha S, Restaino CR, Dayananth P, Zhu H, Cooper A, Carr D, Deng Y, Jin W, Black S, Long B, Liu J, Dinunzio E, Windsor W, Zhang R, Zhao S, Angagaw MH, Pinheiro EM, Desai J, Xiao L, Shipps G, Hruza A, Wang J, Kelly J, Paliwal S, Gao X, Babu BS, Zhu L, Daublain P, Zhang L, Lutterbach BA, Pelletier MR, Philippar U, Siliphaivanh P, Witter D, Kirschmeier P, Bishop WR, Hicklin D, Gilliland DG, Jayaraman L, Zawel L, Fawell S, Samatar AA.

Cancer Discov. 2013 Jul;3(7):742-50. doi: 10.1158/2159-8290.CD-13-0070. Epub 2013 Apr 24.

6.

Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains.

O'Hara JA, Ambe LA, Casella LG, Townsend BM, Pelletier MR, Ernst RK, Shanks RM, Doi Y.

Antimicrob Agents Chemother. 2013 May;57(5):2103-8. doi: 10.1128/AAC.02501-12. Epub 2013 Feb 19.

7.

LPS remodeling is an evolved survival strategy for bacteria.

Li Y, Powell DA, Shaffer SA, Rasko DA, Pelletier MR, Leszyk JD, Scott AJ, Masoudi A, Goodlett DR, Wang X, Raetz CR, Ernst RK.

Proc Natl Acad Sci U S A. 2012 May 29;109(22):8716-21. doi: 10.1073/pnas.1202908109. Epub 2012 May 14. Erratum in: Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13877.

8.

Role of Francisella lipid A phosphate modification in virulence and long-term protective immune responses.

Kanistanon D, Powell DA, Hajjar AM, Pelletier MR, Cohen IE, Way SS, Skerrett SJ, Wang X, Raetz CR, Ernst RK.

Infect Immun. 2012 Mar;80(3):943-51. doi: 10.1128/IAI.06109-11. Epub 2012 Jan 3.

9.

Genome-wide screen in Francisella novicida for genes required for pulmonary and systemic infection in mice.

Kraemer PS, Mitchell A, Pelletier MR, Gallagher LA, Wasnick M, Rohmer L, Brittnacher MJ, Manoil C, Skerett SJ, Salama NR.

Infect Immun. 2009 Jan;77(1):232-44. doi: 10.1128/IAI.00978-08. Epub 2008 Oct 27.

10.

Inhalation of Francisella novicida Delta mglA causes replicative infection that elicits innate and adaptive responses but is not protective against invasive pneumonic tularemia.

West TE, Pelletier MR, Majure MC, Lembo A, Hajjar AM, Skerrett SJ.

Microbes Infect. 2008 Jun;10(7):773-80. doi: 10.1016/j.micinf.2008.04.008. Epub 2008 Apr 22.

11.

A Francisella mutant in lipid A carbohydrate modification elicits protective immunity.

Kanistanon D, Hajjar AM, Pelletier MR, Gallagher LA, Kalhorn T, Shaffer SA, Goodlett DR, Rohmer L, Brittnacher MJ, Skerrett SJ, Ernst RK.

PLoS Pathog. 2008 Feb 8;4(2):e24. doi: 10.1371/journal.ppat.0040024.

12.

Type IV pili-mediated secretion modulates Francisella virulence.

Hager AJ, Bolton DL, Pelletier MR, Brittnacher MJ, Gallagher LA, Kaul R, Skerrett SJ, Miller SI, Guina T.

Mol Microbiol. 2006 Oct;62(1):227-37.

13.

Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals.

Tyner JW, Kim EY, Ide K, Pelletier MR, Roswit WT, Morton JD, Battaile JT, Patel AC, Patterson GA, Castro M, Spoor MS, You Y, Brody SL, Holtzman MJ.

J Clin Invest. 2006 Feb;116(2):309-21.

14.
15.

Epileptiform activity in hippocampal slice cultures exposed chronically to bicuculline: increased gap junctional function and expression.

Samoilova M, Li J, Pelletier MR, Wentlandt K, Adamchik Y, Naus CC, Carlen PL.

J Neurochem. 2003 Aug;86(3):687-99.

16.

Neuroprotective strategies in epilepsy.

Carlen PL, Pelletier MR, Ouanounou A, Tymianski M, Zhang L.

Adv Exp Med Biol. 2002;497:209-24. Review.

PMID:
11993734
17.

Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency.

Li J, Pelletier MR, Perez Velazquez JL, Carlen PL.

Mol Cell Neurosci. 2002 Feb;19(2):138-51.

PMID:
11860268
18.

Analysis of single K(ATP) channels in mammalian dentate gyrus granule cells.

Pelletier MR, Pahapill PA, Pennefather PS, Carlen PL.

J Neurophysiol. 2000 Nov;84(5):2291-301.

19.

Antiepileptic efficacy of topiramate: assessment in two in vitro seizure models.

Jahromi SS, Pelletier MR, McDonald PJ, Khosravani H, Carlen PL.

Brain Res. 2000 Jul 28;872(1-2):20-8.

PMID:
10924671
20.
21.
22.

Repeated tetanic stimulation in piriform cortex in vitro: epileptogenesis and pharmacology.

Pelletier MR, Carlen PL.

J Neurophysiol. 1996 Dec;76(6):4069-79.

PMID:
8985901
23.

Tetraethylammonium-induced synaptic plasticity in rat neocortex.

Pelletier MR, Hablitz JJ.

Cereb Cortex. 1996 Nov-Dec;6(6):771-80.

PMID:
8922333
24.

Benzodiazepine antagonists reduce epileptiform discharges in rat hippocampal slices.

Polc P, Jahromi SS, Facciponte G, Pelletier MR, Zhang L, Carlen PL.

Epilepsia. 1996 Oct;37(10):1007-14.

PMID:
8822701
25.

Stat1 depends on transcriptional synergy with Sp1.

Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ.

J Biol Chem. 1995 Dec 22;270(51):30264-7.

26.

Benzodiazepine antagonist flumazenil reduces hippocampal epileptiform activity.

Polc P, Jahromi SS, Facciponte G, Pelletier MR, Zhang L, Carlen PL.

Neuroreport. 1995 Jul 31;6(11):1549-52.

PMID:
7579146
27.

Altered desensitization produces enhancement of EPSPs in neocortical neurons.

Pelletier MR, Hablitz JJ.

J Neurophysiol. 1994 Aug;72(2):1032-6.

PMID:
7983510
28.

Pathway specificity of noradrenergic plasticity in the dentate gyrus.

Pelletier MR, Kirkby RD, Jones SJ, Corcoran ME.

Hippocampus. 1994 Apr;4(2):181-8.

PMID:
7951692
30.

Infusions of alpha-2 noradrenergic agonists and antagonists into the amygdala: effects on kindling.

Pelletier MR, Corcoran ME.

Brain Res. 1993 Dec 31;632(1-2):29-35.

PMID:
7908598
31.

Intra-amygdaloid infusions of clonidine retard kindling.

Pelletier MR, Corcoran ME.

Brain Res. 1992 Dec 11;598(1-2):51-8.

PMID:
1486503
32.

Low-level cadmium exposure increases one-way avoidance in juvenile rats.

Pelletier MR, Satinder KP.

Neurotoxicol Teratol. 1991 Nov-Dec;13(6):657-62.

PMID:
1779954
33.

Destabilization of lens protein conformation by glutathione mixed disulfide.

Liang JN, Pelletier MR.

Exp Eye Res. 1988 Jul;47(1):17-25.

PMID:
3409984
34.
35.

Front surface fluorometric study of lens insoluble proteins.

Liang JN, Pelletier MR, Chylack LT Jr.

Curr Eye Res. 1988 Jan;7(1):61-7.

PMID:
3359806
36.

Spectroscopic studies on the mixed disulfide formation of lens crystallin with glutathione.

Liang JN, Pelletier MR.

Exp Eye Res. 1987 Aug;45(2):197-206.

PMID:
3653289

Supplemental Content

Loading ...
Support Center